ORIGINAL RESEARCH
Published on 02 Jun 2026
Differentiating naturally occurring and disease associated autoantibodies in MPO-ANCA vasculitis through immunogenomic and epitope comparisons
doi 10.3389/fmed.2026.1784607
- 1,081 views
- Frontiers in Medicine
- Rheumatology
- Research Topics
- Comprehensive Insights into ANCA Vasculitis: From Immunopathology to Treatment Strategies
Comprehensive Insights into ANCA Vasculitis: From Immunopathology to Treatment Strategies
970
Total downloads
8,526
Total views and downloads
Articles
REVIEW
Accepted on 31 May 2026
BEYOND CLINICAL CRITERIA: EMERGING BIOMARKERS AND ADVANCED IM-ING IN THE DIAGNOSIS, MONITORING AND TREATMENT OF VASCULITIDES
- 130 views
ORIGINAL RESEARCH
Accepted on 25 May 2026
Hypogammaglobulinaemia in patients with ANCA-associated vasculitis treated with Rituximab
- 359 views
CASE REPORT
Published on 21 May 2026
Low-dose rituximab for MPO-ANCA-associated hypertrophic pachymeningitis with delayed onset of renal involvement: a case report
doi 10.3389/fmed.2026.1843169
- 352 views
ORIGINAL RESEARCH
Published on 13 May 2026
Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis
doi 10.3389/fimmu.2026.1787558
- 651 views
REVIEW
Published on 02 Mar 2026
Immune checkpoint imbalance in ANCA-associated vasculitis: insights into disease activity and precision immunotherapy
doi 10.3389/fmed.2026.1773241
- 1,052 views
ORIGINAL RESEARCH
Published on 09 Feb 2026
The predictive value of baseline systemic inflammation response index and systemic immune-inflammation index for the risk of infection within 6 months following initial immunosuppressive treatment in patients with ANCA-associated vasculitis
doi 10.3389/fimmu.2026.1718901
- 1,305 views
- 1 citation
ORIGINAL RESEARCH
Published on 06 Feb 2026
Incidence and clinical features of ANCA-associated vasculitis before and during the COVID-19 pandemic: experience from a single-center in Northern Spain
doi 10.3389/fmed.2026.1766518
- 1,165 views
Published in
Frontiers in Medicine
Rheumatology
Other participating journals
Frontiers in Genetics
- 2.8 impact factor
- 6.2 citescore
Frontiers in Molecular Biosciences
- 4.0 impact factor
- 8.8 citescore
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore